Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to study the safety, effectiveness, tolerability and dosing
regimen of risperidone, and olanzapine, in the treatment of mania in Bipolar Disorder I and
Bipolar II Disorder in preschool children over an 8 week period. We hypothesize that these
atypical neuroleptics may be effective in treating pediatric mania, with a lower risk of
extrapyramidal side effects.